摘要
目的:探讨直接经皮冠状动脉腔内成形术(PTCA)与冠状动脉内溶栓(ICT)治疗急性心肌梗塞(AMI)的近期临床疗效。方法:回顾分析1993年8月~1996年12月AMI胸痛后45分钟~6小时〔平均(3.4±1.6)小时〕入院患者52例临床资料,其中1995年8月前24例行国产尿激酶ICT,1995年8月后28例行直接PTCA,以AMI溶栓试验(TIMI)3级血流为血管再通标准。结果:ICT与直接PTCA2组血管再通率分别为41.7%和89.3%(P<0.001),再通血管残留狭窄平均为90.4%±6.7%和14.5%±10.3%(P<0.001),血管再通距胸痛发病时间2组差异无显著性(P>0.05),再通存活患者梗塞后早期(起病后30日内)心绞痛发生率分别为30.0%(3/10)和4.3%(1/23),P<0.05。结论:在条件和设备允许的医院,可优先考虑直接PTCA治疗AMI,以获彻底可靠的血管再通,ICT可作为PTCA失败后的补充措施。
Objective:To compare the recent curative effects between direct percutaneous transluminal coronary angioplasty (PTCA) and intracoronary thrombolysis (ICT) in patients with acute myocardial infarction (AMI).Methods:From August 1993 to December 1996,52 patients with AMI were admitted to hospital within 075 ̄600 hours 〔average(34±16)hours〕 after angina.Among the cases,24 cases were treated by ICT with Chinamade urokinase before August 1995,and the other 28 cases were treated by PTCA after August 1995.The grade 3 perfusion of the thrombolysis in myocardial infarction (TIMI) was used as the standard of coronary artery repatentcy.Results:The repatency rates of the coronary artery in ICT and PTCA were 417% and 893%,respectively (P<0001).The incidences of remained stricture in the repatency coronary artery were 904%±67% and 145%±103%,respectively (P<0001).There was no difference in interval from angina to coronary artery repatency between 2 groups (P>005).In addition,the incidences of premature angina in survivors with repatency were 300% (3/10) and 43% (1/23),respectively (P<005).Conclusions:In order to acquire complete coronary artery repatency,it is the first choice to treat AMI by use of PTCA in the hospital wherever conditions and facilities are permitted.ICT can be used as a complementary measure if PTCA treatment are failed.
出处
《中国危重病急救医学》
CSCD
1998年第1期35-38,共4页
Chinese Critical Care Medicine
关键词
心肌梗塞
溶栓治疗
冠状动脉内
PTCA
acute myocardial infarction
intracoronary thrombolysis
percutaneous transluminal coronary angioplasty